Navigation Links
Clongen Laboratories Announces Formation of Separate Clinical Diagnostics and Contract Research Divisions
Date:11/15/2011

GERMANTOWN, Md., Nov. 15, 2011 /PRNewswire/ -- Since its inception in 1999, Clongen Laboratories, a CLIA licensed facility with a Maryland Clinical Laboratory license, has focused on improving human health by refining diagnostic tests for infectious diseases and providing contract research services for pharmaceutical, biotechnology, government, and academic institutions.

The advanced molecular diagnostics technology Clongen Laboratories uses in their Clinical Diagnostics Division offers a powerful tool in the screening of a wide range of infectious diseases. This allows healthcare practitioners to better diagnose and treat their patients.  One of the main areas of focus in the Clinical Diagnostics Division is tick borne illness testing; however, Clongen Laboratories also offers a large number of other assays, some not offered anywhere else in the US.  The technology platform Clongen Laboratories uses in the Clinical Diagnostics Division is Real Time PCR.  According to Ahmed Kilani, PhD, founder and director of Clongen Labs, this platform allows Clongen Laboratories to rapidly detect infectious agents in clinical samples at very low copy numbers.  The clinician receives laboratory test results in less than a week from the time of sample receipt.  This quick turnaround offers physicians the opportunity to manage clinical cases without delay.

Clongen Laboratories contract research services are performed under GLP and GMP conditions and encompass a wide range of assays available to pharmaceutical, biotechnology, government and academic institutions.  Services include sterility testing, Mycoplasma detection and elimination, Endotoxin testing and removal, and many others.  In recent years, due to the increased risk of bio-warfare agents, Clongen Laboratories developed rapid real time PCR based assays for the detection of all Bio-warfare select agents listed by the Centers for Disease Control and Prevention (CDC).  The contract research division has grown over the years and now covers a large number of established assays; many are required for lot release of biological and pharmaceutical products.  

The company has been enjoying steady growth and will soon obtain licensure in five additional states.  In addition, Clongen Laboratories is establishing satellite facilities in several other states. According to Dr. Kilani, the mission of Clongen Laboratories, which is to promote improved health through better diagnostic testing and research, has remained consistent since the laboratory was established.

Clongen Laboratories began with less than 10 assay offerings.  Today, the clinical diagnostics division offers more than 250 assays for the detection of infectious agents using state of the art technology. In addition to the Molecular Diagnostics offerings, Clongen Laboratories has a licensed routine Microbiology laboratory for the culture and identification of bacteria, yeast and fungi.  

Recent changes to the company's website reflect changes to the organizational structure of the laboratory.  There are two sub-sites for the two business units, the Clinical Diagnostics Division and the Contract Research Division, which are physically and administratively separate.

The two business units perform distinct functions and can be seen at www.Clongen.com

Contact:  Ahmed Kilani, Ph.D., President and Laboratory Director at 301-916-0173 or e-mail akil@clongen.com  


'/>"/>
SOURCE Clongen Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA
2. James Rothman Named Chief Scientific Advisor at VR Laboratories
3. New Scope of Reusable Medical Device Cleaning Validations is Examined in New White Paper from Microtest Laboratories
4. Jeff Kottkamp Chosen to Lead VR Laboratories
5. IDEXX Laboratories Announces Third Quarter Results
6. Matrix Laboratories Completes Name Change to Mylan Laboratories
7. Unity Management Group Receives Large Purchase Order for their AIM Instrumentation Package From Barr Laboratories, Subdivision of TEVA Pharmaceuticals (NASDAQ: TEVA)
8. AIT Laboratories Launches New Tools for Prescription Compliance Monitoring
9. Roche to Expand Coagulation Testing Portfolio, Develop New Systems for Diagnostic Laboratories in US and Canada by 2014
10. Spaulding Clinical Announces New Strategic Partnership With Frontage Laboratories, Inc.
11. "Environmental Monitoring and Certification in Controlled Environments: Meeting Regulations and Achieving Effective Microbial Control for Pharmaceutical and Medical Device Manufacturers" - New White Paper from Microtest Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... ZirMed Inc ., a recognized leader in cloud-based revenue cycle ... ranked #1 by its users for the seventh consecutive year ... ZirMed was recognized as the top-ranked end-to-end revenue cycle management ... 200 beds and holds one of the longest #1 ranking ... ...
(Date:9/12/2017)... reviews on the independent review site Consumer Affairs have ... hearing aids, ranking it higher than Miracle Ear ™, Beltone™, ... ... Aids ... that provides high performance, state-of-the-art, German-engineered hearing aids directly to consumers ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
Breaking Medicine News(10 mins):